Related Experiment Video
Updated: May 4, 2026
05:31
A Fluorescent Screening Assay for Identifying Modulators of GIRK Channels
Published on: April 24, 2012
13.9K
A biochemical screen for GroEL/GroES inhibitors.
Steven M Johnson1, Orzala Sharif2, Puiying Annie Mak2
1Indiana University, School of Medicine, Department of Biochemistry and Molecular Biology, 635 Barnhill Dr., Indianapolis, IN 46202, USA.
Bioorganic & Medicinal Chemistry Letters
|January 15, 2014
Summary
Researchers screened 700,000 small molecules to find inhibitors of the GroEL/GroES protein refolding cycle. Twenty-one potent inhibitors were identified, paving the way for new molecular probes.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Chaperonins like GroEL/GroES are essential for protein folding in cells.
- Dysfunctional chaperonins are implicated in various diseases.
- Targeting chaperonin activity is a potential therapeutic strategy.
Purpose of the Study:
- To identify small molecule inhibitors of the GroEL/GroES chaperonin system.
- To develop molecular probes for studying chaperonin function.
- To establish a foundation for novel therapeutic interventions.
Main Methods:
- High-throughput screening of a large chemical library (700,000 compounds).
- Assay development for GroEL/GroES-mediated protein refolding.
- Dose-response analysis to determine inhibitor potency (IC50 values).
Main Results:
- Identified 235 initial inhibitors of the GroEL/GroES refolding cycle.
- Confirmed 21 potent inhibitors with IC50 values below 10 μM.
- Established a validated set of compounds for further investigation.
Conclusions:
- The study successfully identified novel small molecule inhibitors of GroEL/GroES.
- These compounds serve as valuable starting points for developing molecular probes.
- This work advances the understanding of chaperonin biochemistry and potential drug development.
